BioMarin Pharmaceutical Recent News
Short Sellers Still Attracted To Biotech Stocks
3 More Surges In Biotech Short Interest (AMGN, MDVN, PCYC)
Surges In Biotech Short Interest (INCY, PCYC, REGN)
Short Interest Rises As Biotechs Fall (AMGN, CELG, DNDN)
Celgene, Pharmacyclics Lead Biotech Short Interest Trend (CELG, MDVN, PCYC)
BioMarin, Medivation Buck Biotech Short Interest Trend (BIIB, BMRN, MDVN)
Amgen, BioMarin Lead Biotech Short Interest Trend (AMGN, BIIB, BMRN)
BioMarin Bucks Biotech Short Interest Trend (BIIB, BMRN, MDVN)
New Year Short Interest Swings In Biotech (BIIB, BMRN, MDVN)
Celgene, Dendreon Lead Short Interest Trend In Biotechs (BMRN, CELG, DNDN)
Rising Short Interest In Pharmacyclics, Other Biotechs (AMGN, GILD, PCYC)
Biogen Idec, Pharmacyclics See Surges In Short Interest (BIIB, CELG, PCYC)
Gilead Sciences Leads In Rising Short Interest Among Biotechs
Short Sellers Retreat From Biogen Idec, Move On Pharmacyclics (BIIB, BMRN, PCYC)
Short Sellers Move On Amgen, Vertex (AMGN, PCYC, VRTX)
BioMarin, Celgene Lead Trend in Biotech Short Interest (BRMN, CELG, REGN)
Alexion, Pharmacyclics Buck Trend in Biotech Short Interest (ALXN, CELG, PCYC)
BioMarin, Prestige Brands and Other Top Performing Health Care Stocks in November
Dendreon, Pharmacyclics and Other Biotech Takeover Targets
Wells Fargo Resumes Coverage On BioMarin With $23-$28 Valuation Range